share_log

Cantor Fitzgerald Reiterates Overweight on Asensus Surgical, Maintains $1 Price Target

Cantor Fitzgerald Reiterates Overweight on Asensus Surgical, Maintains $1 Price Target

坎托·菲茨杰拉德重申对Asensus Surgical增持,维持1美元的目标股价
Benzinga ·  2023/08/22 10:37

Cantor Fitzgerald analyst Ross Osborn reiterates Asensus Surgical (AMEX:ASXC) with a Overweight and maintains $1 price target.

坎托·菲茨杰拉德分析师罗斯·奥斯本重申了Asensus Surgical(AMEX: ASXC)的增持,并维持1美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发